196 related articles for article (PubMed ID: 33472018)
1. Optimal treatment in locally advanced cervical cancer.
Gennigens C; De Cuypere M; Hermesse J; Kridelka F; Jerusalem G
Expert Rev Anticancer Ther; 2021 Jun; 21(6):657-671. PubMed ID: 33472018
[No Abstract] [Full Text] [Related]
2. Adjuvant Chemotherapy in Locally Advanced Cervical Cancer After Treatment with Concomitant Chemoradiotherapy--Room for Improvement?
Jelavić TB; Miše BP; Strikic A; Ban M; Vrdoljak E
Anticancer Res; 2015 Jul; 35(7):4161-5. PubMed ID: 26124372
[TBL] [Abstract][Full Text] [Related]
3. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy.
Chargari C; Mazeron R; Dunant A; Gouy S; Petit C; Maroun P; Uzan C; Annede P; Bentivegna E; Balleyguier C; Genestie C; Pautier P; Leary A; Lhomme C; Deutsch E; Morice P; Haie-Meder C
Clin Exp Metastasis; 2016 Dec; 33(8):775-785. PubMed ID: 27530648
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
Angeles MA; Baissas P; Leblanc E; Lusque A; Ferron G; Ducassou A; Martínez-Gómez C; Querleu D; Martinez A
Int J Gynecol Cancer; 2019 Mar; 29(3):480-486. PubMed ID: 30712019
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
7. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer.
Houvenaeghel G; Lelievre L; Rigouard AL; Buttarelli M; Jacquemier J; Viens P; Gonzague-Casabianca L
Gynecol Oncol; 2006 Jul; 102(1):74-9. PubMed ID: 16406062
[TBL] [Abstract][Full Text] [Related]
8. Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial.
Köhler C; Mustea A; Marnitz S; Schneider A; Chiantera V; Ulrich U; Scharf JP; Martus P; Vieira MA; Tsunoda A
Am J Obstet Gynecol; 2015 Oct; 213(4):503.e1-7. PubMed ID: 25986030
[TBL] [Abstract][Full Text] [Related]
9. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
[TBL] [Abstract][Full Text] [Related]
10. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
[TBL] [Abstract][Full Text] [Related]
12. MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
Laliscia C; Gadducci A; Mattioni R; Orlandi F; Giusti S; Barcellini A; Gabelloni M; Morganti R; Neri E; Paiar F
Tumori; 2022 Aug; 108(4):376-385. PubMed ID: 34235995
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G
Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992
[TBL] [Abstract][Full Text] [Related]
14. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
[TBL] [Abstract][Full Text] [Related]
16. Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experience.
Ogorodniitchouk O; Aunier J; Bousarsar A; Lahmamssi C; Sotton S; Ouaz H; Moreno-Acosta P; Moslemi D; Molekzadehmoghani M; Langrand-Escure J; Magne N; Vallard A
Cancer Radiother; 2021 Jul; 25(5):463-468. PubMed ID: 34023215
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
[TBL] [Abstract][Full Text] [Related]
19. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
